John S. Link
- Oncology top 5%
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 7
- Global Cancer Incidence and Screening 3
- Colorectal Cancer Treatments and Studies 3
- Immunology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 4
- Radiopharmaceutical Chemistry and Applications 3
-
- Breast Cancer Treatment Studies 3
-
- Glycosylation and Glycoproteins Research 2
- Co-authors
- James WaismanThomas M. WheelerMakoto OhoriPeter T. ScardinoRobert Alan NagourneySteven S. EvansMary L. DisisLupe G. Salazar
- Journals
- Journal of Clinical Oncology (8 papers)Clinical Breast Cancer (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesCzechiaTürkiye
In The Last Decade
John S. Link
22 papers receiving 818 citations
Peers
Comparison fields: 5 of 78
- Oncology 487
- Immunology 250
- Pulmonary and Respiratory Medicine 287
- Radiology, Nuclear Medicine and Imaging 150
- Cancer Research 94
Countries citing papers authored by John S. Link
This map shows the geographic impact of John S. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Link more than expected).
Fields of papers citing papers by John S. Link
This network shows the impact of papers produced by John S. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Link. The network helps show where John S. Link may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John S. Link, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 0 | |
| 2 | 2013 | 33 | |
| 3 | 2011 | 1 | |
| 4 | 2009 | 64 | |
| 5 | 2009 | 224 | |
| 6 | 2008 | 42 | |
| 7 | 2008 | 16 | |
| 8 | 2007 | 26 | |
| 9 | 2007 | 3 | |
| 10 | 2004 | 4 | |
| 11 | 2000 | 10 | |
| 12 | 2000 | 95 | |
| 13 | 1999 | 41 | |
| 14 | A breast cancer care report card. An assessment of performance and a pursuit of value. | 1997 | 8 |
| 15 | 1993 | 163 | |
| 16 | 1991 | 3 | |
| 17 | 1989 | 17 | |
| 18 | 1987 | 22 | |
| 19 | 1978 | 8 | |
| 20 | 1977 | 39 |
About John S. Link
John S. Link is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 23 papers that have together received 862 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Global Cancer Incidence and Screening (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Breast Cancer Treatment Studies (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Oncology (487 citations), Immunology (250 citations) and Pulmonary and Respiratory Medicine (287 citations). John S. Link has collaborated with scholars based in United States, Czechia and Türkiye. Frequent co-authors include James Waisman, Thomas M. Wheeler, Makoto Ohori, Peter T. Scardino, Robert Alan Nagourney, Steven S. Evans, Mary L. Disis, Lupe G. Salazar, Patricia A. Fintak and Andrew L. Coveler. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, Molecular Cancer Therapeutics, Cancer and The American Journal of Surgical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.